NO20006249L - Acetylkolinforsterkere - Google Patents

Acetylkolinforsterkere

Info

Publication number
NO20006249L
NO20006249L NO20006249A NO20006249A NO20006249L NO 20006249 L NO20006249 L NO 20006249L NO 20006249 A NO20006249 A NO 20006249A NO 20006249 A NO20006249 A NO 20006249A NO 20006249 L NO20006249 L NO 20006249L
Authority
NO
Norway
Prior art keywords
acetylcholine
compound
benzylpiperizin
forb
hemifumarate
Prior art date
Application number
NO20006249A
Other languages
English (en)
Other versions
NO20006249D0 (no
Inventor
Derek T Chalmers
Susumoto Sato
Tadayuki Koda
Original Assignee
Arena Pharm Inc
Ssp Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharm Inc, Ssp Company Ltd filed Critical Arena Pharm Inc
Publication of NO20006249L publication Critical patent/NO20006249L/no
Publication of NO20006249D0 publication Critical patent/NO20006249D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives kinolinderivater med mekanistisk dualegenskaper, i søknaden kalt "acetylkolinforsterkere", dvs forbindelser som viser acetylkolinesterase (AChE) inhiberingsaktivitet, og 5-HT3 reseptorantagonistaktivitet. En spesiell foretrukket forbindelse er 2-[2-(l-benzylpiperizin-4-yl)etyl]-2,3-dihydro-9- metoksy-lH-pyrrolo[3,4-b]kinolin-l-on hemifumarat, her kalt forbindelse A ("forb.A.")
NO20006249A 1998-06-10 2000-12-08 Acetylkolinforsterkere NO20006249D0 (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8873798P 1998-06-10 1998-06-10
US9166698P 1998-07-02 1998-07-02
US10941398P 1998-11-20 1998-11-20
US11508999P 1999-01-07 1999-01-07
US13688799P 1999-06-01 1999-06-01
PCT/US1999/012886 WO1999064421A1 (en) 1998-06-10 1999-06-09 Acetylcholine enhancers
US09/328,643 US6218402B1 (en) 1998-06-10 1999-06-09 Acetylcholine enhancers

Publications (2)

Publication Number Publication Date
NO20006249L true NO20006249L (no) 2000-12-08
NO20006249D0 NO20006249D0 (no) 2000-12-08

Family

ID=27557353

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006249A NO20006249D0 (no) 1998-06-10 2000-12-08 Acetylkolinforsterkere

Country Status (12)

Country Link
US (2) US6218402B1 (no)
EP (1) EP1086102A1 (no)
JP (1) JP2004508272A (no)
KR (1) KR20010072598A (no)
CN (1) CN1138775C (no)
AU (1) AU751590B2 (no)
BR (1) BR9911079A (no)
CA (1) CA2331794A1 (no)
IL (1) IL139254A0 (no)
MX (1) MXPA00012248A (no)
NO (1) NO20006249D0 (no)
WO (1) WO1999064421A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3929250B2 (ja) * 2001-03-08 2007-06-13 株式会社ルネサステクノロジ 半導体装置
WO2004035577A2 (en) * 2002-10-16 2004-04-29 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
EP1677778A2 (en) * 2003-10-09 2006-07-12 Inverseon, Inc. Method of treating airway diseases with beta-adrenergic inverse agonists
US20070276024A1 (en) * 2003-10-09 2007-11-29 Inverseon , Inc. Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse Agonists
JP2005154320A (ja) * 2003-11-25 2005-06-16 Ss Pharmaceut Co Ltd 眼疾患治療薬
WO2005117904A2 (en) * 2004-04-14 2005-12-15 Gilead Sciences, Inc. Phosphonate analogs of hiv integrase inhibitor compounds
US7528175B2 (en) * 2004-10-08 2009-05-05 Inverseon, Inc. Method of treating airway diseases with beta-adrenergic inverse agonists
CN103992312A (zh) * 2013-02-18 2014-08-20 江苏欧威医药有限公司 1,2,4-噻二唑-3,5-二酮衍生物及其药物组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240934A (en) 1990-10-19 1993-08-31 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
US5190951A (en) 1990-10-19 1993-03-02 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
CA2135253A1 (en) 1994-11-07 1996-05-08 Michael Dennis Compound screening based on a window of chemical-messenger-independent activity

Also Published As

Publication number Publication date
WO1999064421A8 (en) 2000-04-06
CN1138775C (zh) 2004-02-18
US6218402B1 (en) 2001-04-17
AU4955399A (en) 1999-12-30
US6586596B2 (en) 2003-07-01
EP1086102A1 (en) 2001-03-28
NO20006249D0 (no) 2000-12-08
CA2331794A1 (en) 1999-12-16
CN1304411A (zh) 2001-07-18
WO1999064421A1 (en) 1999-12-16
JP2004508272A (ja) 2004-03-18
US20010039284A1 (en) 2001-11-08
AU751590B2 (en) 2002-08-22
BR9911079A (pt) 2001-02-20
IL139254A0 (en) 2001-11-25
WO1999064421B1 (en) 2000-02-24
KR20010072598A (ko) 2001-07-31
MXPA00012248A (es) 2003-04-25

Similar Documents

Publication Publication Date Title
EA200000683A1 (ru) Производные ряда 4-(2-кето-1-бензимидазолинил)пиперидина в качестве агонистов orl1-рецептора
ATE219077T1 (de) Endothelin antagoniste
DK0765314T3 (da) Benzoheterocykliske derivater, der kan anvendes som vasopressin- eller oxytocinmodulatorer
NO308300B1 (no) Heterosykliske forbindelser med tachykininreseptorantagonistaktivitet, og preparat inneholdende disse
ATE350036T1 (de) Tetrahydroquinolin-derivate
DK1052984T3 (da) Antibakterielle midler
WO1999000373A8 (en) Benzimidazole derivatives
EA199800170A1 (ru) Производные 2-(4-замещенного)бензиламино-2-метилпропанамида
NO20006249L (no) Acetylkolinforsterkere
NO20001514L (no) Vitronectin-reseptor-antagonist
BG104447A (en) Biphenylamidine derivatives
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
DK0954521T3 (da) 4-[(thien-3-yl)methyl]-imidazoler med alfa2-adrenoceptor-agonistisk aktivitet
TR199900321T2 (xx) N-(1-nbutil - 4 - piperidil)metil) -3,4-dihidro -2H- (1,3) oksazino (3.2A) indol-10- Karboksamit haz�rlama prosesi ve prosesteki tuzlar ve ara �r�nler.
EP1043311A4 (en) BIPHENYLAMIDINE DERIVATIVES
CA2423357A1 (en) Fused heterocyclic derivatives as phosphodiesterase inhibitors
CA2250929A1 (en) 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity
DE60027204D1 (en) Benzamidinderivate
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
DK369289A (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
TW346483B (en) Benzene derivatives
NO20004075L (no) Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister
TR200100354T2 (tr) NK-2 Antagonist hareketine sahip monosiklik bileşimler ve oluşumlar.
CA2485739A1 (en) Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone
CA2250930A1 (en) 4-[(thien-3-yl)methyl] imidazole derivatives having .alpha.2-adrenoceptor agonistic activity

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application